Natural products as sources of new drugs over the 30 years from 1981 to 2010 - Test2 - elhamkhani - TriplyDB

Natural products as sources of new drugs over the 30 years from 1981 to 2010

Natural products as sources of new drugs over the 30 years from 1981 to 2010

http://www.wikidata.org/entity/Q29616640

about

Polyacetylenes from Notopterygium incisum--new selective partial agonists of peroxisome proliferator-activated receptor-gamma Sloth hair as a novel source of fungi with potent anti-parasitic, anti-cancer and anti-bacterial bioactivity Penicillium nalgiovense Laxa isolated from Antarctica is a new source of the antifungal metabolite amphotericin B.Antimicrobial and antiproliferative activities of stingless bee Melipona scutellaris geopropolis Discovery and resupply of pharmacologically active plant-derived natural products: A review Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gamma Blue-Print Autophagy: Potential for Cancer Treatment Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells Exploiting the Biosynthetic Potential of Type III Polyketide Synthases Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project Integrated (Meta) Genomic and Synthetic Biology Approaches to Develop New Biocatalysts Cannabis sativa: The Plant of the Thousand and One Molecules Chemical Diversity and Biological Properties of Secondary Metabolites from Sea Hares of Aplysia Genus Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States Microbial Biotransformation to Obtain New Antifungals Potential Use of Phenolic Acids as Anti-Candida Agents: A Review Anti-hypertensive Herbs and their Mechanisms of Action: Part I Capturing Biological Activity in Natural Product Fragments by Chemical Synthesis Natural Products as Tools for Defining How Cellular Metabolism Influences Cellular Immune and Inflammatory Function during Chronic Infection Synthetic biology for pharmaceutical drug discovery Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery?Plant derived substances with anti-cancer activity: from folklore to practice Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases Biologically Active Metabolites Synthesized by Microalgae.Metabolic engineering of Bacillus subtilis for terpenoid production The Sound of Silence: Activating Silent Biosynthetic Gene Clusters in Marine Microorganisms Potential Antiviral Agents from Marine Fungi: An Overview Manipulation of fungal development as source of novel secondary metabolites for biotechnology Constellation pharmacology: a new paradigm for drug discovery Combating pathogenic microorganisms using plant-derived antimicrobials: a minireview of the mechanistic basis Epothilones: From discovery to clinical trials Development of advanced macrosphelides: potent anticancer agents Lessons learned from the transformation of natural product discovery to a genome-driven endeavor Trypanocidal activity of marine natural products Animals in a bacterial world: opportunities for chemical ecology Alkaloids from marine invertebrates as important leads for anticancer drugs discovery and development Phytol, a diterpene alcohol from chlorophyll, as a drug against neglected tropical disease Schistosomiasis mansoni Genomic and metabolomic insights into the natural product biosynthetic diversity of a feral-hog-associated Brevibacillus laterosporus strain

P2860

Q21090765-87AAAFF9-E7E8-4AC7-910A-513DB6DBA455 Q21132370-52004F18-091D-4FA1-8758-D4BEA5E91B26 Q21146447-9519DC38-94C6-4409-BAE5-6BFEF23EA2A0 Q21254679-9C97AD4C-8E16-43DA-B707-2D09BBE05241 Q22252341-3680B8FA-32B9-41DA-9084-50CE768B0888 Q24567657-5339457E-336D-4E94-9851-0B54CDD67567 Q26741800-7F9BA28B-C267-44B1-A7E2-5BA0848BF818 Q26744724-BC87776D-3BC8-4D3E-8CBD-116C26018050 Q26747526-87A58FEA-D3E8-43CB-8A79-98CBA85178A0 Q26749061-4B20C866-3E7B-47B2-BED1-04E60C1BF3F7 Q26749192-99D16095-1359-4615-A201-2B4AF8F1ABCB Q26752345-0287D464-F69C-4263-847B-93EAA82304E4 Q26766409-4DA4F427-F28E-47E9-A028-EEC44CD60563 Q26767090-0B9281B2-F500-4AFB-90C2-52D26FA229C3 Q26767376-5AA251BA-DE40-4478-898B-3F66C1720090 Q26770689-C4258703-3B30-4DBB-A0DD-4ED90C447161 Q26770692-ADA2E052-FBD7-4939-9311-8BBB208FD9E6 Q26772791-55832935-099E-457F-B33A-0DF6171360B5 Q26772873-32773A03-BF86-41C3-A559-6822A26E6F59 Q26775036-8899B492-785C-42E3-B6C4-4CAD8E2A8741 Q26775582-3223F224-AA47-4C34-ABAF-0B82222B031D Q26777448-3568464C-98E4-4599-ABB8-FD83A08855B5 Q26778522-DE71C03C-A5BF-4DFA-9249-8AB7A762CB05 Q26781498-521E5274-DB47-4FCA-A50A-3F60B7BD0B5A Q26784341-92A24387-D654-4CEF-BB8E-3282AE9E0198 Q26784427-A17E74E6-8436-4750-A2E4-E27DAEE38513 Q26786823-35FA967B-7B5C-4A3C-9265-7378BC46BD26 Q26799211-7F666D9A-370F-4121-BA5B-7010F457C3F3 Q26800107-3C458CE8-176E-4C07-90A6-A2C6C78E6ED4 Q26823231-B4386981-A4F6-4BE9-84D7-EB462DA05317 Q26823685-DC9AB181-2382-494E-A0B3-3722E26A06B4 Q26851551-65123681-8B54-40FC-9981-C9703792EED4 Q27005747-143EE3C4-D0F5-4178-81F0-29F90A592016 Q27006946-EDA81A43-21F4-41AC-A87F-41ED18A3DB9E Q27007021-2B3FD3F3-6A61-4E77-BB91-3FE562238AC4 Q27008593-7383FCF8-629D-4656-A8B1-69D94A3FB2CE Q27011275-B831E6DD-EE63-401D-ACD5-0FBF79D58A72 Q27012072-46A740E6-BAD5-45FA-A010-4CBBDCEF48E7 Q27304960-6DA0A64F-CADF-47A4-AE66-FDFD65675635 Q27318800-AA9196DA-0450-4FF0-BA4D-82F156785EB0

P2860

Natural products as sources of new drugs over the 30 years from 1981 to 2010

http://www.wikidata.org/entity/Q29616640

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Natural products as sources of new drugs over the 30 years from 1981 to 2010

@ast

Natural products as sources of new drugs over the 30 years from 1981 to 2010

@en

type

label

Natural products as sources of new drugs over the 30 years from 1981 to 2010

@ast

Natural products as sources of new drugs over the 30 years from 1981 to 2010

@en

prefLabel

Natural products as sources of new drugs over the 30 years from 1981 to 2010

@ast

Natural products as sources of new drugs over the 30 years from 1981 to 2010

@en

P1433

Q29616640-F4479047-5A0A-43F4-A956-1D607E25DA8C

P1476

Q29616640-EABE86F3-DF33-46A1-98CE-512E926A1D07

P2093

Q29616640-3AC864AA-75C8-4720-9553-135DBF11D421

Q29616640-E819924F-17F8-42EF-8E20-D27E6EBBCCC1

P2860

Q29616640-014E6A7C-C905-4D48-8443-E7AA215DF3B5

Q29616640-0B67A966-6B6A-4E2B-BE99-DFEA315E247F

Q29616640-145DADA2-D4A1-4344-BA3F-84A46008BCFF

Q29616640-15E8BCFC-0AB3-436C-94C0-F1427063CDBE

Q29616640-29BADDE3-B99E-438B-9DA3-5BB4CEAC5B99

Q29616640-2A9A684D-0351-4305-AFA2-1BB954BD5077

Q29616640-2B717A34-41D5-440C-9EC6-8D19B567B713

Q29616640-2E8CEC43-DC82-4675-B8BA-82E198716F26

Q29616640-30AA411F-4C63-498F-986E-EE2214899AB8

Q29616640-3B8F29D1-DDE7-4890-A3A0-661396E51698

P304

Q29616640-C72ADBB9-2DD6-48C0-A4C5-F2ADF47141C2

P31

Q29616640-945BE1A5-2CFA-4E38-BFF2-CC492EDDA209

P3181

Q29616640-439E4E33-EAB2-413F-A71B-9B18B9FCFB7F

P356

Q29616640-690E8BEC-7D0C-4B20-BF85-EA8ED61FF5EA

P407

Q29616640-F38EFC7C-B589-4FF3-95ED-70FDC1901AE2

P433

Q29616640-ADE822F8-F10E-484B-BB80-D5A70059EE8A

P478

Q29616640-B05680BD-251E-4B69-AA1F-EE13AF236128

P577

Q29616640-778F1C9E-A36E-4F44-B099-8B9A47F2D3F1

P5875

Q29616640-1C981906-0D47-4FAD-AD57-DD5954EA8067

P698

Q29616640-91BD676F-5A28-45A7-B783-151B732C49BB

P932

Q29616640-BA073EA4-CB75-4272-9190-2DAC2502FCEB

P3181

P356

P1433

Journal of Natural Products

P1476

Natural products as sources of new drugs over the 30 years from 1981 to 2010

@en

P2093

Cragg GM

http://www.w3.org/2001/XMLSchema#string

Newman DJ

http://www.w3.org/2001/XMLSchema#string

P2860

Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability

Metabolic engineering for microbial production of shikimic acid

A planning strategy for diversity-oriented synthesis

Shikimic acid production by a modified strain of E. coli (W3110.shik1) under phosphate-limited and carbon-limited conditions

Natural products as sources of new drugs over the last 25 years

Design of compound libraries based on natural product scaffolds and protein structure similarity clustering (PSSC).

The economies of synthesis.

Mother nature's combinatorial libraries; their influence on the synthesis of drugs.

Marine drugs from sponge-microbe association--a review

Combinatorial synthesis of natural products.

P304

311-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

123264

http://www.w3.org/2001/XMLSchema#string

P356

10.1021/NP200906S

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221816309

http://www.w3.org/2001/XMLSchema#string

P698

22316239

http://www.w3.org/2001/XMLSchema#string

P932

3721181

http://www.w3.org/2001/XMLSchema#string